286 related articles for article (PubMed ID: 36996866)
1. No association between genetically predicted C-reactive protein levels and colorectal cancer survival in Korean: two-sample Mendelian randomization analysis.
Choi CK; Yang JH; Shin MH; Cho SH; Kweon SS
Epidemiol Health; 2023; 45():e2023039. PubMed ID: 36996866
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.
Wang X; Dai JY; Albanes D; Arndt V; Berndt SI; Bézieau S; Brenner H; Buchanan DD; Butterbach K; Caan B; Casey G; Campbell PT; Chan AT; Chen Z; Chang-Claude J; Cotterchio M; Easton DF; Giles GG; Giovannucci E; Grady WM; Hoffmeister M; Hopper JL; Hsu L; Jenkins MA; Joshi AD; Lampe JW; Larsson SC; Lejbkowicz F; Li L; Lindblom A; Le Marchand L; Martin V; Milne RL; Moreno V; Newcomb PA; Offitt K; Ogino S; Pharoah PDP; Pinchev M; Potter JD; Rennert HS; Rennert G; Saliba W; Schafmayer C; Schoen RE; Schrotz-King P; Slattery ML; Song M; Stegmaier C; Weinstein SJ; Wolk A; Woods MO; Wu AH; Gruber SB; Peters U; White E
Int J Epidemiol; 2019 Jun; 48(3):767-780. PubMed ID: 30476131
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.
Prins BP; Abbasi A; Wong A; Vaez A; Nolte I; Franceschini N; Stuart PE; Guterriez Achury J; Mistry V; Bradfield JP; Valdes AM; Bras J; Shatunov A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Lu C; Han B; Raychaudhuri S; Bevan S; Mayes MD; Tsoi LC; Evangelou E; Nair RP; Grant SF; Polychronakos C; Radstake TR; van Heel DA; Dunstan ML; Wood NW; Al-Chalabi A; Dehghan A; Hakonarson H; Markus HS; Elder JT; Knight J; Arking DE; Spector TD; Koeleman BP; van Duijn CM; Martin J; Morris AP; Weersma RK; Wijmenga C; Munroe PB; Perry JR; Pouget JG; Jamshidi Y; Snieder H; Alizadeh BZ
PLoS Med; 2016 Jun; 13(6):e1001976. PubMed ID: 27327646
[TBL] [Abstract][Full Text] [Related]
4. Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study.
Hua X; Dai JY; Lindström S; Harrison TA; Lin Y; Alberts SR; Alwers E; Berndt SI; Brenner H; Buchanan DD; Campbell PT; Casey G; Chang-Claude J; Gallinger S; Giles GG; Goldberg RM; Gunter MJ; Hoffmeister M; Jenkins MA; Joshi AD; Ma W; Milne RL; Murphy N; Pai RK; Sakoda LC; Schoen RE; Shi Q; Slattery ML; Song M; White E; Marchand LL; Chan AT; Peters U; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1349-1358. PubMed ID: 33972368
[TBL] [Abstract][Full Text] [Related]
5. Body mass index and colorectal cancer risk: A Mendelian randomization study.
Suzuki S; Goto A; Nakatochi M; Narita A; Yamaji T; Sawada N; Katagiri R; Iwagami M; Hanyuda A; Hachiya T; Sutoh Y; Oze I; Koyanagi YN; Kasugai Y; Taniyama Y; Ito H; Ikezaki H; Nishida Y; Tamura T; Mikami H; Takezaki T; Suzuki S; Ozaki E; Kuriki K; Takashima N; Arisawa K; Takeuchi K; Tanno K; Shimizu A; Tamiya G; Hozawa A; Kinoshita K; Wakai K; Sasaki M; Yamamoto M; Matsuo K; Tsugane S; Iwasaki M
Cancer Sci; 2021 Apr; 112(4):1579-1588. PubMed ID: 33506574
[TBL] [Abstract][Full Text] [Related]
6. Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis.
Jun SY; Cho S; Kim MJ; Park JW; Ryoo SB; Jeong SY; Park KJ; Shin A
Cancer Med; 2024 Mar; 13(5):e7084. PubMed ID: 38477501
[TBL] [Abstract][Full Text] [Related]
7. Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study.
Yun Z; Guo Z; Li X; Shen Y; Nan M; Dong Q; Hou L
Cancer Med; 2023 Jun; 12(12):13784-13799. PubMed ID: 37132247
[TBL] [Abstract][Full Text] [Related]
8. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses.
Seyed Khoei N; Jenab M; Murphy N; Banbury BL; Carreras-Torres R; Viallon V; Kühn T; Bueno-de-Mesquita B; Aleksandrova K; Cross AJ; Weiderpass E; Stepien M; Bulmer A; Tjønneland A; Boutron-Ruault MC; Severi G; Carbonnel F; Katzke V; Boeing H; Bergmann MM; Trichopoulou A; Karakatsani A; Martimianaki G; Palli D; Tagliabue G; Panico S; Tumino R; Sacerdote C; Skeie G; Merino S; Bonet C; Rodríguez-Barranco M; Gil L; Chirlaque MD; Ardanaz E; Myte R; Hultdin J; Perez-Cornago A; Aune D; Tsilidis KK; Albanes D; Baron JA; Berndt SI; Bézieau S; Brenner H; Campbell PT; Casey G; Chan AT; Chang-Claude J; Chanock SJ; Cotterchio M; Gallinger S; Gruber SB; Haile RW; Hampe J; Hoffmeister M; Hopper JL; Hsu L; Huyghe JR; Jenkins MA; Joshi AD; Kampman E; Larsson SC; Le Marchand L; Li CI; Li L; Lindblom A; Lindor NM; Martín V; Moreno V; Newcomb PA; Offit K; Ogino S; Parfrey PS; Pharoah PDP; Rennert G; Sakoda LC; Schafmayer C; Schmit SL; Schoen RE; Slattery ML; Thibodeau SN; Ulrich CM; van Duijnhoven FJB; Weigl K; Weinstein SJ; White E; Wolk A; Woods MO; Wu AH; Zhang X; Ferrari P; Anton G; Peters A; Peters U; Gunter MJ; Wagner KH; Freisling H
BMC Med; 2020 Sep; 18(1):229. PubMed ID: 32878631
[TBL] [Abstract][Full Text] [Related]
9. Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration.
Han X; Ong JS; An J; Hewitt AW; Gharahkhani P; MacGregor S
Eur J Epidemiol; 2020 Feb; 35(2):139-146. PubMed ID: 31900758
[TBL] [Abstract][Full Text] [Related]
10. Associations of alcohol and coffee with colorectal cancer risk in East Asian populations: a Mendelian randomization study.
Deng Y; Huang J; Wong MCS
Eur J Nutr; 2023 Mar; 62(2):749-756. PubMed ID: 36239790
[TBL] [Abstract][Full Text] [Related]
11. Noncausal effects of genetic predicted depression and colorectal cancer risk: A Mendelian randomization study.
Wu E; Ni JT; Xie T; Tao L
Medicine (Baltimore); 2022 Aug; 101(34):e30177. PubMed ID: 36042675
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Relationship Between High-sensitivity C-reactive Protein and Kidney Function Employing Mendelian Randomization in the Japanese Community-based J-MICC Study.
Fujii R; Hishida A; Nishiyama T; Nakatochi M; Matsuo K; Ito H; Nishida Y; Shimanoe C; Nakamura Y; Turin TC; Suzuki S; Watanabe M; Ibusuki R; Takezaki T; Mikami H; Nakamura Y; Ikezaki H; Murata M; Kuriki K; Kuriyama N; Matsui D; Arisawa K; Katsuura-Kamano S; Tsukamoto M; Tamura T; Kubo Y; Kondo T; Momozawa Y; Kubo M; Takeuchi K; Wakai K
J Epidemiol; 2022 Nov; 32(11):483-488. PubMed ID: 33612706
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and risk of Alzheimer's disease.
Zhang Z; Wang M; Liu X
Neurobiol Aging; 2022 Jan; 109():259-263. PubMed ID: 34538509
[TBL] [Abstract][Full Text] [Related]
14. Association of plasma C-reactive protein with ischaemic stroke: a Mendelian randomization study.
Zhang X; Wang A; Zhang J; Singh M; Liu D; Zuo Y; Wu L; Song M; Wang W; Feigin V; Wang Y; Zheng D
Eur J Neurol; 2020 Mar; 27(3):565-571. PubMed ID: 31692152
[TBL] [Abstract][Full Text] [Related]
15. Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.
Rodriguez-Broadbent H; Law PJ; Sud A; Palin K; Tuupanen S; Gylfe A; Hänninen UA; Cajuso T; Tanskanen T; Kondelin J; Kaasinen E; Sarin AP; Ripatti S; Eriksson JG; Rissanen H; Knekt P; Pukkala E; Jousilahti P; Salomaa V; Palotie A; Renkonen-Sinisalo L; Lepistö A; Böhm J; Mecklin JP; Al-Tassan NA; Palles C; Martin L; Barclay E; Farrington SM; Timofeeva MN; Meyer BF; Wakil SM; Campbell H; Smith CG; Idziaszczyk S; Maughan TS; Kaplan R; Kerr R; Kerr D; Passarelli MN; Figueiredo JC; Buchanan DD; Win AK; Hopper JL; Jenkins MA; Lindor NM; Newcomb PA; Gallinger S; Conti D; Schumacher F; Casey G; Aaltonen LA; Cheadle JP; Tomlinson IP; Dunlop MG; Houlston RS
Int J Cancer; 2017 Jun; 140(12):2701-2708. PubMed ID: 28340513
[TBL] [Abstract][Full Text] [Related]
16. Genetically determined elevated C-reactive protein associated with primary colorectal cancer risk: Mendelian randomization with lifestyle interactions.
Jung SY; Yu H; Pellegrini M; Papp JC; Sobel EM; Zhang ZF
Am J Cancer Res; 2021; 11(4):1733-1753. PubMed ID: 33948386
[TBL] [Abstract][Full Text] [Related]
17. Blood Lipids and the Risk of Colorectal Cancer: Mendelian Randomization Analyses in the Japanese Consortium of Genetic Epidemiology Studies.
Iwagami M; Goto A; Katagiri R; Sutoh Y; Koyanagi YN; Nakatochi M; Nakano S; Hanyuda A; Narita A; Shimizu A; Tanno K; Hozawa A; Kinoshita K; Oze I; Ito H; Yamaji T; Sawada N; Nakamura Y; Nakamura S; Kuriki K; Suzuki S; Hishida A; Kasugai Y; Imoto I; Suzuki M; Momozawa Y; Takeuchi K; Yamamoto M; Sasaki M; Matsuo K; Tsugane S; Wakai K; Iwasaki M
Cancer Prev Res (Phila); 2022 Dec; 15(12):827-836. PubMed ID: 36040498
[TBL] [Abstract][Full Text] [Related]
18. Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer.
Nimptsch K; Aleksandrova K; Pham TT; Papadimitriou N; Janke J; Christakoudi S; Heath A; Olsen A; Tjønneland A; Schulze MB; Katzke V; Kaaks R; van Guelpen B; Harbs J; Palli D; Macciotta A; Pasanisi F; Yohar SMC; Guevara M; Amiano P; Grioni S; Jakszyn PG; Figueiredo JC; Samadder NJ; Li CI; Moreno V; Potter JD; Schoen RE; Um CY; Weiderpass E; Jenab M; Gunter MJ; Pischon T
BMC Med; 2023 Oct; 21(1):391. PubMed ID: 37833736
[TBL] [Abstract][Full Text] [Related]
19. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.
Nimptsch K; Aleksandrova K; Boeing H; Janke J; Lee YA; Jenab M; Bueno-de-Mesquita HB; Jansen EH; Tsilidis KK; Trichopoulou A; Weiderpass E; Wu C; Overvad K; Tjønneland A; Boutron-Ruault MC; Dossus L; Racine A; Kaaks R; Canzian F; Lagiou P; Trichopoulos D; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Johansson A; Van Guelpen B; Khaw KT; Wareham N; Peeters PH; Quirós JR; Venceslá García A; Molina-Montes E; Dorronsoro M; Chirlaque MD; Barricarte Gurrea A; Key TJ; Duarte-Salles T; Stepien M; Gunter MJ; Riboli E; Pischon T
Int J Cancer; 2015 Mar; 136(5):1181-92. PubMed ID: 25043606
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis.
Zhu M; Ma Z; Zhang X; Hang D; Yin R; Feng J; Xu L; Shen H
BMC Med; 2022 Sep; 20(1):301. PubMed ID: 36117174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
